Latest filing published 04 Feb 2026 for ZEVRA THERAPEUTICS, INC., €23k.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 8 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +31.1%Entry US$4.79 · Close at T+365 US$6.28
- +249.9%Entry US$3.26 · Close at T+365 US$11.42
- +154.6%Entry US$3.92 · Close at T+365 US$9.98
- +0.3%Entry US$11.20 · Close at T+365 US$11.23
- -73.9%Entry US$40.48 · Close at T+365 US$10.58
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Timothy J. Sangiovanni: trading record in brief
This profile gathers the share dealings of Timothy J. Sangiovanni in Zevra Therapeutics, Inc. Between 11 October 2018 and 3 February 2026, the trades on record add up to 13 filings.
Both buying and selling appear: 9 purchases worth €16k, against 2 sales worth €46k. On balance, insiders were net sellers of €30k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 2 option exercises. So far in 2026, the count stands at no purchases and 1 sale.
The median purchase comes to €1,713. 8 out of 8 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Ninety days after publication, 8 purchases show a median change of -12.7%, with the price up in 38% of them. They describe history only and say nothing certain about the share price ahead.
The record was last updated on 4 February 2026 with an open-market sale (€23k) in Zevra Therapeutics, Inc. The last insider purchase was made public on 13 March 2023, 1,336 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Timothy J. Sangiovanni
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,000 shares@ US$9.182746.4% of flowCommon StockSEC:0001698328-26-000004:0
- 6,333 sharesCommon StockSEC:0001698328-26-000002:0
- 3,000 shares@ US$7.862645.1% of flowCommon StockSEC:0001437749-25-004070:0
- 11,666 sharesCommon StockSEC:0001437749-25-002629:0
- 100 shares@ US$4.14Common StockSEC:0001437749-23-006278:1Canonical exit: 8 Jun 2023 (T+90)
- 1,100 shares@ US$4.13978.5% of flowCommon StockSEC:0001437749-23-006278:0Canonical exit: 8 Jun 2023 (T+90)
- 4,000 shares@ US$0.201.4% of flowCommon StockSEC:0001437749-20-005367:0Canonical exit: 11 Jun 2020 (T+90)
- 333 shares@ US$0.250.1% of flowCommon StockSEC:0001437749-20-004693:0Canonical exit: 7 Jun 2020 (T+90)
- 10 shares@ US$0.25250.0% of flowCommon StockSEC:0001437749-20-004693:1Canonical exit: 8 Jun 2020 (T+90)
- 7,657 shares@ US$0.2553.2% of flowCommon StockSEC:0001437749-20-004693:2Canonical exit: 8 Jun 2020 (T+90)
- 3,000 shares@ US$0.743.3% of flowCommon StockSEC:0001437749-19-019060:0Canonical exit: 23 Dec 2019 (T+90)
- 1,500 shares@ US$2.555.4% of flowCommon StockSEC:0001437749-18-018301:0Canonical exit: 9 Jan 2019 (T+90)
- 1,500 shares@ US$2.505.3% of flowCommon StockSEC:0001437749-18-018301:1Canonical exit: 10 Jan 2019 (T+90)
13 of 13 declarations